Health24.com | Milk chocolate, dairy and fatty foods tied to acne in adults

  • The reason for acne in adulthood is most likely related to what you eat
  • A typical Western diet can increase one’s chances of getting pimples
  • Foods like vegetables, fish and more plant-based fare are tied to reductions in acne for adults

Are you plagued by acne even though you’re way past puberty? A new report might have you avoiding certain foods.

The study of more than 24 000 French adults found that sweet and greasy fare – especially milk chocolate, sweetened drinks, dairy products, and sugary or fatty foods – all appeared to raise the odds for zits.

The new findings “appear to support the hypothesis that the Western diet (rich in animal products and fatty and sugary foods) is associated with the presence of acne in adulthood”, said the team led by dermatologist Dr Emilie Sbidian, of Mondor Hospital in Paris.

Food affects hormones

One US dermatologist who read over the report wasn’t surprised.

“This new study confirms what I have always believed, that proper nutrition is an important component of acne treatment,” said Dr Michele Green, of Lenox Hill Hospital in New York City.

The likely culprit? Foods’ effects on hormones, she said.

“One of the reasons that this high ‘glycemic’ diet – high in sugar – causes acne, is that it changes the normal dynamic of one’s hormones,” Green explained. “These high-sugar diets can cause a rise in insulin levels and this affects other hormones, which lead to the development of acne.”

Adding to that, Green said, “there are also ongoing studies looking into the hormones that cows are fed in their feed, which may also have an effect on the development of acne.”

The new study focused on acne in adults, not on people younger than 18 years of age. Unlike many prior studies, this one was especially rigorous. Thousands of French participants filled out researcher-validated 24-hour dietary records over a two-week period. In these food diaries, participants recorded all foods and drinks consumed, and at what amounts.

Quantity matters

They also recorded any incidence of an acne outbreak.

The result: After adjusting for a number of confounding factors, certain foods – dairy, fatty and sugary fare – emerged as potential acne triggers.

Quantity mattered. For example, having one glass of milk per day bumped up the odds of an outbreak by 12%, and a glass of a sugary drink (such as soda) raised it by 18%.

But drink five glasses of either a sugary drink or milk in a day, and your odds of developing zits rose by more than twofold or 76%, respectively.

Fatty foods appeared to do people’s skin no favours, either: One portion of a fatty (think French fries, burgers) food or a sugary treat (sugared donuts, cookies) boosted the odds for an outbreak by 54%, the study found.

And “a complete meal of fatty and sugary products” upped the odds more than eightfold, Sbidian’s group reported.

More than a cosmetic nuisance

Overall, “adults with current acne were found to be less likely to have a healthy dietary pattern,” the French team concluded.

And what about chocolate? Intake of milk chocolate did seem tied to acne risk, bumping up the odds for an outbreak by 28%, the researchers found. But consumption of less fatty dark chocolate was actually tied to a 10% lower odds for acne.

Healthier foods – such as vegetables, fish and more plant-based fare – were also tied to reductions in acne for adults, the findings showed.

For many, acne isn’t just a cosmetic nuisance, Green noted.

“Acne patients suffer from low self-esteem and depression, and many go on to have physical acne scars, which they carry on their face for a lifetime,” she said.

In fact, “acne is an extremely important and emotional issue that frequently gets neglected,” Green added.

“More studies need to be done but it is so important to investigate the role of diet, nutrition and chemicals, and their effect on blood hormonal levels, acne, and our health in general,” she said.

The study was published online on 10 June in JAMA Dermatology.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Health24.com | An HIV drug you only take twice a year?

  • Longer-acting HIV medications could free people from taking daily pills
  • An experimental drug is now able to maintain active levels in the blood of patients for more than six months
  • Scientists are, however, still working on ways to potentially cure HIV/Aids

Scientists are reporting an early step toward an HIV drug that could potentially be taken only a couple of times per year.

A single injection of the experimental drug, called lenacapavir, was able to lower blood levels of HIV in a small group of patients. And it was capable of maintaining active levels in the blood for more than six months.

It all raises the possibility of one day having an HIV treatment that only needs to be taken twice a year.

The current treatment regimens for HIV – combinations of oral drugs often called “cocktails” – generally work quite well, said study co-author Dr Martin Rhee.

No more daily pills

“But patients often say that over time, taking daily pills can be a burden,” said Rhee, director of clinical research for Gilead Sciences, Inc. – which is developing lenacapavir.

So the hope is that longer-acting HIV medications could “free people from daily pills,” Rhee said.

Beyond that, he noted, longer-acting drugs could potentially offer a simpler way to prevent HIV in high-risk people: Right now, that’s done with a daily pill regimen known as PrEP (pre-exposure prophylaxis).

However, much more work remains ahead. The new study, published on 1 July  in the journal Nature, offers a “proof of principle” that a dosing interval of every six months is possible, Rhee said.

The researchers found that in 40 healthy people, lenacapavir appeared safe and could remain active in the body for more than six months. And in 32 people with previously untreated HIV, a single injection reduced viral levels in the blood within nine days.

It’s encouraging that the drug is “amenable to dosing every six months”, said Dr Rajesh Gandhi, an infectious disease physician at Massachusetts General Hospital, in Boston.

A pair of drugs

Gandhi, who is also chair-elect of the HIV Medicine Association, agreed there is a need for longer-acting HIV drugs.

The catch is that HIV is not treated with one drug alone – to keep the virus suppressed and limit the chances of it becoming resistant to medication.

So, for any twice-a-year regimen to become a reality, Gandhi explained, two long-acting drugs would have to be paired.

“So the question is, what do you partner this drug with?” he said.

Rhee said Gilead is working on such a partner. More immediately, the researchers will study the effects of lenacapavir, taken every six months, in HIV patients who’ve tried many standard drugs and are resistant to them.

Easier adherence

Other longer-acting drugs for HIV are further along – though the doses are more frequent than twice a year.

Researchers are studying a combination of two injection drugs – cabotegravir and rilpivirine – that is given monthly. The hope is to keep HIV suppressed in patients who have got the virus down to very low levels with standard oral drugs.

Meanwhile, cabotegravir is also being tested for preventing HIV in high-risk people, according to the US National Institutes of Health. In those trials, injections are given every two months.

But while infrequent doses would be convenient and – hopefully – make adherence easier, there are safety questions. If people have side effects from the drug, for example, does that mean they are stuck with them for six months?

To help avoid that, Gandhi said, studies have been using a “lead-in” phase: Patients first take oral versions of the long-acting drugs, to make sure they can tolerate them.

Still committed to finding a cure

But another concern, Gandhi said, is what could happen if patients miss or delay an injection: As levels of the drug wane in the body, the virus could come roaring back, and possibly develop resistance to the medication.

Rhee agreed that is an issue that will face all long-acting HIV medications under development.

Still, the progress toward new options is encouraging, according to Gandhi. People with HIV should know that scientists are still working on new treatments, he said – including ways to potentially cure it.

“We’re still committed to finding a cure,” Gandhi said.

Image credit: iStock

Share Button

Health24.com | Follow exercise guidelines and you’ll live longer, study says

  • According to a recent study, exercise can definitely increase one’s lifespan
  • Data indicate that only 16% of participants in the study did the recommended amount of exercise
  • The risk of death from any cause was 40% lower among those who did both sufficient muscle-strengthening and aerobic activities

Getting the recommended amount of exercise could cut your risk of early death, a new study indicates.

US government guidelines recommend at least 150 minutes of moderate-intensity or at least 75 minutes of vigorous-intensity aerobic activity a week. They also suggest adults do moderate or greater intensity muscle-strengthening exercise at least two days a week.

That effort pays off in longevity, according to the study published on 1 July in BMJ.

“Our findings support that the physical activity levels recommended in the 2018 physical activity guidelines for Americans provide important survival benefits,” researcher Bo Xi and colleagues wrote in a journal news release.

Benefits higher for vigorous exercise

“Additionally, in accordance with the guidelines, more physical activity than the minimum recommendation could provide greater health benefits,” Xi, a professor of cardiovascular epidemiology at Shandong University in China, and co-authors said.

To assess the benefits of these guidelines, the researchers analysed data from nearly 480 000 US adults, ages 18 to 85, who were followed for an average of nearly nine years.

During that time, only 16% of the participants fully met the recommended activity levels, and nearly 60 000 died.

Compared to those who didn’t meet the recommended activity levels, the risk of death from any cause was 11% lower among those who engaged in sufficient muscle-strengthening exercise. It was 29% lower among those who did sufficient aerobic exercise, and 40% lower among those who did both sufficient muscle-strengthening and aerobic activities.

The researchers also found that adults who did sufficient aerobic exercise had a lower risk of death from these specific causes – heart disease, cancer, chronic lower respiratory tract diseases, accidents and injuries, Alzheimer’s disease, and diabetes. Those who did sufficient strengthening exercises had a lower risk of death from heart disease, cancer and chronic lower respiratory tract disease.

Survival benefits were slightly higher for vigorous exercise than for light to moderate activity.

The study doesn’t establish a direct cause-and-effect relationship. Still, inactivity is a global public health issue. It’s estimated that inactivity was responsible for 6 to 10% of major chronic non-communicable diseases and 9% of early deaths worldwide in 2008.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Coronavirus: Spanish study casts doubt on herd immunity feasibility

A Lancet study estimates that around just 5% of the Spanish population has developed antibodies.

Share Button

Coronavirus: Majority testing positive have no symptoms

A survey by the Office for National Statistics looked at who had been infected in the community in England.

Share Button

Health24.com | Seizures after vaccination don’t affect kids’ development

  • Children may suffer febrile seizures after being vaccinated
  • This can be distressing for both the child and the parents
  • Australian researchers, however, found that vaccines are safe and that these seizures will not negatively affect kids’ development

Kids who have a fever-related seizure after getting a vaccine won’t have developmental and behavioural problems as a result, according to a new study.

These so-called febrile seizures do not affect children’s development whether they occur after a vaccination or not, the researchers said.

“A febrile seizure can occur following vaccination and understandably can be quite distressing to parents. It can also cause parents to lose confidence in future vaccinations,” said study author Dr Lucy Deng. She is a paediatrician at the National Center for Immunization Research and Surveillance in Sydney, Australia.

“Now, parents will be relieved to hear that having a febrile seizure following vaccination does not affect the child’s development,” Deng added.

Emerging new diseases

For the study, Deng’s team compared 62 kids who had a fever-related seizure within two weeks of a shot with 70 who had a seizure from another cause and 90 who never had a seizure. All were about two years old.

The investigators found no differences in development, thinking skills or behaviour among the three groups.

“At a time when there is a global resurgence of measles and new diseases are emerging, our findings are particularly important in reassuring parents and providers on the safety of vaccines,” Deng said in a news release from the American Academy of Neurology.

The report was published online on 1 July in the journal Neurology.

Image credit: Unsplash

NEXT ON HEALTH24X

Share Button

Health24.com | Animal tests point to possible path to ultrafast insulin

  • Pharmaceutical companies have been trying to develop a faster-acting insulin for decades
  • A new formulation could translate to a fourfold decrease in the time insulin takes to reach peak activity in humans
  • Researchers have confirmed the ultrafast action of their formulation in pigs with diabetes

An experimental ultrafast-acting insulin could work four times more quickly than current fast-acting formulas, researchers say.

For the study, the researchers focused on a form of insulin called monomeric insulin. Though its structure should, in theory, allow it to act faster, monomeric insulin is too unstable for practical use, so the Stanford University team had to find a way around that problem.

“The insulin molecules themselves are fine, so we wanted to develop a ‘magic fairy dust’ that you add into a vial that would help to fix the stability problem,” said senior author Eric Appel, assistant professor of materials science and engineering.

“People often focus on the therapeutic agents in a drug formulation but, by focusing only on the performance additives – parts that were once referred to as ‘inactive ingredients’ – we can achieve really big advancements in the overall efficacy of the drug,” Appel added in a university news release.

Ultrafast action

His team identified an additive polymer that could stabilize monomeric insulin for more than 24 hours in stressed conditions. Current commercial fast-acting insulin stays stable for six to 10 hours under the same conditions.

The researchers confirmed the ultrafast action of their formulation in pigs with diabetes, the most advanced non-human animal model. Their results were published on 1 July in the journal Science Translational Medicine.

In the pigs, the experimental insulin reached 90% of its peak activity within five minutes of injection, while commercial fast-acting insulin began showing significant activity only after 10 minutes.

The experimental insulin’s activity peaked at about 10 minutes; commercial insulin required 25 minutes.

Though results of animal experiments are not always the same in humans, the researchers said the difference could be significant. It could translate to a fourfold decrease in the time insulin takes to reach peak activity in people.

“It’s really unprecedented,” Appel said. “This has been a major target for many big pharmaceutical companies for decades.”

Additional tests are underway with an eye to applying for US Food and Drug Administration (FDA) approval for clinical trials in humans.

Image credit: iStock

Share Button

Do we know what we want in a romantic partner? No more than a random stranger would

We all can describe our ideal partner. Perhaps they are funny, attractive and inquisitive. Or maybe they are down-to-earth, intelligent and thoughtful. But do we actually have special insight into ourselves, or are we just describing positive qualities that everyone likes?

New research coming out of the University of California, Davis, suggests that people’s ideal partner preferences do not reflect any unique personal insight. The paper, “Negligible Evidence That People Desire Partners Who Uniquely Fit Their Ideals,” was published last week in the Journal of Experimental Social Psychology.

“The people in our study could very easily list their top three attributes in an ideal partner,” noted Jehan Sparks, former UC Davis doctoral student and lead author of the study. “We wanted to see whether those top three attributes really mattered for the person who listed them. As it turns out, they didn’t.”

In the research, more than 700 participants nominated their top three ideals in a romantic partner — attributes like funny, attractive or inquisitive. Then they reported their romantic desire for a series of people they knew personally: Some were blind date partners, others were romantic partners, and others were friends.

Participants experienced more romantic desire to the extent that these personal acquaintances possessed the top three attributes. If Vanessa listed funny, attractive and inquisitive, she experienced more desire for partners who were funny, attractive and inquisitive.

“On the surface, this looks promising,” notes Paul Eastwick, a professor in the UC Davis Department of Psychology and co-author.

“You say you want these three attributes, and you like the people who possess those attributes. But the story doesn’t end there.” — Professor Paul Eastwick, UC Davis

What would a stranger say?

The researchers included a twist: Each participant also considered the extent to which the same personal acquaintances possessed three attributes nominated by some other random person in the study. For example, if Kris listed down-to-earth, intelligent and thoughtful as her own top three attributes, Vanessa also experienced more desire for acquaintances who were down-to-earth, intelligent and thoughtful.

“So in the end, we want partners who have positive qualities,” said Sparks, “but the qualities you specifically list do not actually have special predictive power for you.” The authors take these findings to mean that people don’t have special insight into what they personally want in a partner.

Eastwick compared it to ordering food at a restaurant. “Why do we order off the menu for ourselves? Because it seems obvious that I will like what I get to pick. Our findings suggest that, in the romantic domain, you might as well let a random stranger order for you — you’re just as likely to end up liking what you get.”

The findings have implications for the way people approach online dating. People commonly spend many hours perusing online dating profiles in the search of someone who specifically matches their ideals. Sparks and colleagues’ research suggests that this effort may be misplaced.

“It’s really easy to spend time hunting around online for someone who seems to match your ideals,” notes Sparks. “But our research suggests an alternative approach: Don’t be too picky ahead of time about whether a partner matches your ideals on paper. Or, even better, let your friends pick your dates for you.”

Story Source:

Materials provided by University of California – Davis. Original written by Karen Nikos-Rose. Note: Content may be edited for style and length.

Share Button

Atomic ‘Swiss army knife’ precisely measures materials for quantum computers

It images single atoms. It maps atomic-scale hills and valleys on metal and insulating surfaces. And it records the flow of current across atom-thin materials subject to giant magnetic fields. Scientists at the National Institute of Standards and Technology (NIST) have developed a novel instrument that can make three kinds of atom-scale measurements simultaneously. Together, these measurements can uncover new knowledge about a wide range of special materials that are crucial for developing the next generation of quantum computers, communications and a host of other applications.

From smartphones to multicookers, devices that perform several functions are often more convenient and potentially less expensive than the single-purpose tools they replace, and their multiple functions often work better in concert than separately. The new three-in-one instrument is a kind of Swiss Army knife for atom-scale measurements. NIST researcher Joseph Stroscio and his colleagues, including Johannes Schwenk and Sungmin Kim, present a detailed recipe for building the device in the Review of Scientific Instruments.

“We describe a blueprint for other people to copy,” Stroscio said. “They can modify the instruments they have; they don’t have to buy new equipment.”

By simultaneously conducting measurements on scales ranging from nanometers to millimeters, the instrument can help researchers zero in on the atomic origins of several unusual properties in materials that may prove invaluable for a new generation of computers and communication devices. These properties include the resistance-less flow of electric current, quantum jumps in electrical resistance that could serve as novel electrical switches, and new methods to design quantum bits, which could lead to solid-state-based quantum computers.

“By connecting the atomic with the large scale, we can characterize materials in a way that we couldn’t before,” said Stroscio.

Although the properties of all substances have their roots in quantum mechanics — the physical laws that govern the Lilliputian realm of atoms and electrons — quantum effects can often be ignored on large scales such as the macroscopic world we experience every day. But for a highly promising class of materials known as quantum materials, which typically consist of one or more atomically thin layers, strong quantum effects between groups of electrons persist over large distances and the rules of quantum theory can dominate even on macroscopic length scales. These effects lead to remarkable properties that can be harnessed for new technologies.

To study these properties more precisely, Stroscio and his colleagues combined in a single instrument a trio of precision measuring devices. Two of the devices, an atomic force microscope (AFM) and a scanning tunneling microscope (STM), examine microscopic properties of solids, while the third tool records the macroscopic property of magnetic transport — the flow of current in the presence of a magnetic field.

“No single type of measurement provides all the answers for understanding quantum materials,” said NIST researcher Nikolai Zhitenev. “This device, with multiple measuring tools, provides a more comprehensive picture of these materials.”

To build the instrument, the NIST team designed an AFM and a magnetic-transport-measuring device that were more compact and had fewer moving parts than previous versions. They then integrated the tools with an existing STM.

Both an STM and an AFM use a needle-sharp tip to examine the atomic-scale structure of surfaces. An STM maps the topography of metal surfaces by placing the tip within a fraction of a nanometer (billionth of a meter) of the material under study. By measuring the flow of electrons that tunnels out of the metal surface as the sharp tip hovers just above the material, the STM reveals the sample’s atomic-scale hills and valleys.

In contrast, an AFM measures forces by changes in the frequency at which its tip oscillates as it hovers over a surface. (The tip is mounted on a miniature cantilever, which allows the probe to swing freely.) The oscillation frequency shifts as the sharp probe senses forces, such as the attraction between molecules, or the electrostatic forces with the material’s surface. To measure magnetic transport, a current is applied across a surface immersed in a known magnetic field. A voltmeter records the voltage at different places on the device, revealing the electrical resistance of the material.

The ensemble is mounted inside a cryostat, a device that chills the system to one-hundredth of a degree above absolute zero. At that temperature, the random quantum jitter of atomic particles is minimized and large-scale quantum effects become more pronounced and easier to measure. The three-in-one device, which is shielded from external electrical noise, is also five to 10 times more sensitive than any previous set of similar instruments, approaching the fundamental quantum noise limit that can be achieved at low temperatures.

Although it’s possible for three entirely independent instruments — an STM, an AFM and a magnetic transport setup — to make the same measurements, inserting and then retracting each tool can disturb the sample and diminish the accuracy of the analysis. Separate instruments can also make it difficult to replicate the exact conditions, such as the temperature and rotation angle between each ultrathin layer of the quantum material, under which previous measurements were made.

To achieve the goal of a three-in-one instrument with high sensitivity, the NIST team partnered with an international team of experts, including Franz Giessibl from the University of Regensburg, Germany, who invented a highly effective AFM known as the qPlus AFM. The team chose a compact design that increased the stiffness of the microscope and outfitted the system with a series of filters to screen out radio frequency noise. The atomically thin needle of the STM doubled as the force sensor for the AFM, which was based on a new force sensor design created by Giessibl for the three-in-one instrument.

For Stroscio, a pioneer in building ever-more-sophisticated STMs, the new device is something of a pinnacle in a more than three-decade career in scanning probe microscopy. His team, he noted, had been struggling for several years to dramatically reduce the electrical noise in its measurements. “We have now achieved the ultimate resolution given by thermal and quantum limits in this new instrument,” Stroscio said.

“This feels like I’ve climbed the highest peak of the Rocky Mountains,” he added. “It’s a nice synthesis of everything I’ve learned over the last 30-plus years.”

Share Button

Coronavirus: Fear over rise in animal-to-human diseases

A report says a rise in animal-to-human diseases will continue without urgent action.

Share Button